Sialyl-Tn serves as a potential therapeutic target for ovarian cancer.
Saved in:
| Title: | Sialyl-Tn serves as a potential therapeutic target for ovarian cancer. |
|---|---|
| Authors: | Al-Alem L; Vincent Center for Reproductive Biology, Department of Obstetrics and Gynecology, Massachusetts General Hospital, Boston, MA, 02114, USA.; Obstetrics, Gynecology and Reproductive Biology, Harvard Medical School, Boston, MA, 02115, USA., Prendergast JM; Siamab Therapeutics, Inc, Newton, MA, 02458, USA., Clark J; Siamab Therapeutics, Inc, Newton, MA, 02458, USA., Zarrella B; Vincent Center for Reproductive Biology, Department of Obstetrics and Gynecology, Massachusetts General Hospital, Boston, MA, 02114, USA., Zarrella DT; Vincent Center for Reproductive Biology, Department of Obstetrics and Gynecology, Massachusetts General Hospital, Boston, MA, 02114, USA., Hill SJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, 02215, USA.; Division of Molecular and Cellular Oncology, Dana-Farber Cancer Institute, Boston, MA, 02215, USA.; Department of Medicine, Harvard Medical School, Boston, MA, 02115, USA., Growdon WB; Vincent Center for Reproductive Biology, Department of Obstetrics and Gynecology, Massachusetts General Hospital, Boston, MA, 02114, USA.; Obstetrics, Gynecology and Reproductive Biology, Harvard Medical School, Boston, MA, 02115, USA.; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Massachusetts General Hospital, Boston, MA, 02114, USA., Pooladanda V; Vincent Center for Reproductive Biology, Department of Obstetrics and Gynecology, Massachusetts General Hospital, Boston, MA, 02114, USA.; Obstetrics, Gynecology and Reproductive Biology, Harvard Medical School, Boston, MA, 02115, USA., Spriggs DR; Division of Hematology-Oncology, Massachusetts General Hospital, 55 Fruit St, Boston, MA, 02114, USA.; Department of Medicine, Massachusetts General Hospital, Boston, MA, 02114, USA., Cramer D; Obstetrics and Gynecology Epidemiology Center, Brigham and Women's Hospital, Boston, MA, 02115, USA., Elias KM; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Brigham and Women's Hospital, Boston, MA, 02115, USA., Nazer RI; Siamab Therapeutics, Inc, Newton, MA, 02458, USA., Skates SJ; Biostatistics Center, Massachusetts General Hospital, Boston, MA, 02114, USA., Behrens J; Siamab Therapeutics, Inc, Newton, MA, 02458, USA., Dransfield DT; Siamab Therapeutics, Inc, Newton, MA, 02458, USA., Rueda BR; Vincent Center for Reproductive Biology, Department of Obstetrics and Gynecology, Massachusetts General Hospital, Boston, MA, 02114, USA. brueda@mgh.harvard.edu.; Obstetrics, Gynecology and Reproductive Biology, Harvard Medical School, Boston, MA, 02115, USA. brueda@mgh.harvard.edu.; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Massachusetts General Hospital, Boston, MA, 02114, USA. brueda@mgh.harvard.edu. |
| Source: | Journal of ovarian research [J Ovarian Res] 2024 Apr 02; Vol. 17 (1), pp. 71. Date of Electronic Publication: 2024 Apr 02. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: BioMed Central Country of Publication: England NLM ID: 101474849 Publication Model: Electronic Cited Medium: Internet ISSN: 1757-2215 (Electronic) Linking ISSN: 17572215 NLM ISO Abbreviation: J Ovarian Res Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
